Melanoma Recurrent

Oncology

Prevalence

75.0 / 100K

Incidence

23.0 / 100K/yr

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Melanoma Recurrent?

There are 1 clinical trial targeting Melanoma Recurrent tracked by BioSniper.

What is the prevalence of Melanoma Recurrent?

The estimated prevalence of Melanoma Recurrent is approximately 75.0 per 100,000 population.

Deep-dive into Melanoma Recurrent

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Melanoma Recurrent — Drugs in Development & Clinical Trials | BioSniper